Scholarly Index
Amy L. Olson
Boehringer Ingelheim (United States); 6,058 total citations; 107 total publications; best world rank #345
Boehringer Ingelheim (United States)
6,058Total citations
107Total publications
31H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 660 | US 281 | 96.90 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 345 | US 121 | 95.53 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 922 | US 225 | 87.76 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 962 | US 186 | 80.48 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 615 | US 183 | 77.35 |